Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea
NCT01557166Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of liraglutide in obstructive sleep apnea (OSA), sponsored by Novo Nordisk. Started Jun 2012; status: completed.
02
Drugs
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01557166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01557166.